MTOR and breast carcinoma: PI3K, Akt, and dual PI3K/mTOR inhibitors have been shown to enhance FOXO3a nuclear localization in breast cancer cells (Serra et al., 2011) and we have shown here that effective PI3Kα inhibition resulted in FOXO3a nuclear relocation.